-
First Wave BioPharma (FWBI) Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.8 Million Gross Proceeds Priced
-
First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.8 Million Gross Proceeds Priced
-
First Wave BioPharma (FWBI) Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.0 Million Gross Proceeds Priced At-the-Market
-
First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.0 Million Gross Proceeds Priced At-the-Market
-
First Wave BioPharma (FWBI) Prices $2.1M Offering at $0.64/sh
-
First Wave BioPharma, Inc. Announces Pricing of $2.1 Million Public Offering
-
First Wave BioPharma (FWBI) Announces Exercise of Warrants and Issuance of New Warrants in a $2.4M Private Placement
-
First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $2.4 Million Gross Proceeds Priced At-the-Market
-
First Wave BioPharma Announces $4.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
-
First Wave BioPharma to Participate in ‘Fireside Chat’ at the 35th Annual Roth Conference
-
UPDATE: First Wave BioPharma, Inc. (FWBI) PT Lowered to $25 at Roth Capital
-
First Wave BioPharma to Participate in ”Fireside Chat” at the 34th Annual Roth Conference

